ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BXN Bioxyne Ltd

0.03
-0.001 (-3.23%)
24 Jan 2025 - Closed
Delayed by 20 minutes

Bioxyne Financial Summary

The current BXN market cap is 61.4M. The company's latest EPS is AUD -0.0065 and P/E is -4.62.

Year End 30 June 2024 20202021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 2.33M2.2M2.48M5.31M9.76M
Operating Income -651k-255k-139k-2M-13.23M
Net Income -593k-496k-237k-1.94M-13.33M
Year End 30 June 2024 20202021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Assets 3.34M2.68M2.92M17.69M6.7M
Total Liabilities 726k745k982k2.69M3.4M
Total Equity 2.61M1.93M1.94M15.01M3.3M

Cash Flow

Year End 30 June 2024 20202021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Operating 49k53k435k-841k-3.56M
Investing -33k N/A -6k3.96M-493k
Financing -52k-47k N/A 947k1.21M
Market Cap 61.4M
Price to Earnings Ratio -4.62
Price to Sales Ratio 6.25
Price to Cash Ratio 60
Price to Book Ratio 18.61
Dividend Yield -

Share Statistics

Shares Outstanding 2.05B
Average Volume (1 week) 1.2M
Average Volume (1 Month) 1.7M
52 Week Change 100.00%
52 Week High 0.033
52 Week Low 0.004
Spread (Intraday) 0 (6.45%)

Company Info

Company Name Bioxyne Ltd
Address suite 506, level 5
sydney, new south wales 2000
Website https://www.bioxyne.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock